semaglutide ema Eye disorder is a 'very rare' side effect of weight-loss drugs, concludes review EMA Approves Semaglutide as First

Clinical Nutrition, 41(6), 1456-1464

PMID: 16 McIntyreRSSoczynskaJKChaDSWoldeyohannesHODaleRSAlsuwaidanMTet al

For those on GLP-1 medications, adequate protein becomes even more critical because these drugs suppress appetite so effectively that total food intake drops, risking muscle loss if protein falls too low

Dosing Regimen: Treatment begins with a dose escalation schedule to help your body adjust: 0.25 mg once weekly for the first 4 weeks

Clinicians should maintain awareness of these variables when prescribing GLP-1 receptor agonists, particularly in patients with pre-existing osteoporosis or multiple fracture risk factors